Neonc Technologies Inc.
NTHI | NASDAQ
$3.33
+$0.07 (+2.15%)
At close: Sep 21, 2026, 4:00 PM ET
$3.40
+$0.07 (+2.10%)
Pre-market:
Sep 22, 2026, 5:25 AM ET
Company Profile
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Key Executives
| Name | Position |
|---|---|
| Amir Farrokh Heshmatpour | President, Chief Executive Officer, Executive Chairman & Secretary |
| Keithly A. Garnett | Chief Financial Officer |
| David Choi | Chief Accounting Officer |
| Josh Neman-Ebrahim | Chief Clinical Officer |
| Thomas C. Chen | Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 05, 2026 | 10-K/A | [Amend] Annual Report |
| May 04, 2026 | 4 | Filing |
| Apr 28, 2026 | 4 | Filing |
| Apr 24, 2026 | 4 | Filing |
| Apr 24, 2026 | 4 | Filing |
| Apr 24, 2026 | 8-K | Current Report |
| Apr 23, 2026 | 4 | Filing |
| Apr 16, 2026 | EFFECT | Filing |
| Apr 16, 2026 | 8-K | Current Report |
| Apr 16, 2026 | 424B5 | Filing |
Neonc Technologies Inc.
| Country | United States |
| IPO Date | Mar 25, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Amir Farrokh Heshmatpour |
Contact Details
23975 Park Sorrento Calabasas,
California 91302 United States
Stock Details
| Ticker Symbol | NTHI |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001979414 |
| CUSIP Number | 64051A101 |
| ISIN Number | US64051A1016 |
| SIC Code | n/a |
Add to Watchlist
Select watchlists to add or remove NTHI